Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Edwards

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
Journal of Virology|May 18, 2001
Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?B R Dix, S J Edwards, A W Braithwaite
British Journal of Haematology|June 1, 1991
Proteolysis of factor VIII heavy chain polypeptides in plasma and concentratesG Kemball-Cook, S J Edwards, T W Barrowcliffe
The Journal of Experimental Medicine|January 22, 2017
Human immunity against EBV-lessons from the clinicStuart G Tangye, Umaimainthan Palendira, Emily S J Edwards
Biochimica Et Biophysica Acta|November 28, 1986
The effects of alpha- and beta-adrenergic agents, Ca2+ and insulin on 2-deoxyglucose uptake and phosphorylation in perfused rat heartS Rattigan, S J Edwards, M Hettiarachchi, et al.
International Journal of Clinical Practice|June 4, 2009
Indirect comparisons of treatments based on systematic reviews of randomised controlled trialsS J Edwards, M J Clarke, S Wordsworth, et al.
Lancet (London, England)|September 23, 1997
Why "underpowered" trials are not necessarily unethicalS J Edwards, R J Lilford, D Braunholtz, et al.
Social Science & Medicine (1982)|January 7, 1999
Informed consent for clinical trials: in search of the "best" methodS J Edwards, R J Lilford, J Thornton, et al.
BMC Public Health|March 14, 2024
Pandemic lockdowns: who feels coerced and why? - a study on perceived coercion, perceived pressures and procedural justice during the UK COVID-19 lockdownsV Ranieri, C Gordon, S K Kamboj, et al.
The Journal of Parasitology|October 1, 1988
GM-CSF produced by recombinant vaccinia virus or in GM-CSF transgenic mice has no effect in vivo on murine cutaneous leishmaniasisL M Corcoran, D Metcalf, S J Edwards, et al.
Frontiers in Immunology|September 2, 2022
Editorial: Contemporary challenges in diagnosis and treatment of predominantly antibody deficiencyRohan Ameratunga, Hassan Abolhassani, Paul J Maglione, et al.
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Journal of Virology|May 18, 2001
Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?B R Dix, S J Edwards, A W Braithwaite
British Journal of Haematology|June 1, 1991
Proteolysis of factor VIII heavy chain polypeptides in plasma and concentratesG Kemball-Cook, S J Edwards, T W Barrowcliffe
The Journal of Experimental Medicine|January 22, 2017
Human immunity against EBV-lessons from the clinicStuart G Tangye, Umaimainthan Palendira, Emily S J Edwards
Biochimica Et Biophysica Acta|November 28, 1986
The effects of alpha- and beta-adrenergic agents, Ca2+ and insulin on 2-deoxyglucose uptake and phosphorylation in perfused rat heartS Rattigan, S J Edwards, M Hettiarachchi, et al.
International Journal of Clinical Practice|June 4, 2009
Indirect comparisons of treatments based on systematic reviews of randomised controlled trialsS J Edwards, M J Clarke, S Wordsworth, et al.
Lancet (London, England)|September 23, 1997
Why "underpowered" trials are not necessarily unethicalS J Edwards, R J Lilford, D Braunholtz, et al.
Social Science & Medicine (1982)|January 7, 1999
Informed consent for clinical trials: in search of the "best" methodS J Edwards, R J Lilford, J Thornton, et al.
BMC Public Health|March 14, 2024
Pandemic lockdowns: who feels coerced and why? - a study on perceived coercion, perceived pressures and procedural justice during the UK COVID-19 lockdownsV Ranieri, C Gordon, S K Kamboj, et al.
The Journal of Parasitology|October 1, 1988
GM-CSF produced by recombinant vaccinia virus or in GM-CSF transgenic mice has no effect in vivo on murine cutaneous leishmaniasisL M Corcoran, D Metcalf, S J Edwards, et al.
Frontiers in Immunology|September 2, 2022
Editorial: Contemporary challenges in diagnosis and treatment of predominantly antibody deficiencyRohan Ameratunga, Hassan Abolhassani, Paul J Maglione, et al.
Pageof 12